anmeldenOMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.04.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 22.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 22.04.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 22.04.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 22.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 22.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
| 21.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.04.22 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 20.04.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 20.04.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 19.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 14.04.22 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Jefferies & Company Inc. | |
| 14.04.22 | Ericsson (Telefon L.M.Ericsson) (B) Overweight | JP Morgan Chase & Co. | |
| 14.04.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.04.22 | Kone Neutral | Goldman Sachs Group Inc. | |
| 13.04.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.04.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.04.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 07.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.04.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 06.04.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 05.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 05.04.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 01.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
